Unboosted atazanavir
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Unboosted atazanavir, covering 2019-12-05 to 2019-12-05. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Trial Assessing Once Daily Raltegravir Administration (800 mg QD) in HIV-1-Infected Patients Receiving Unboosted Atazanavir (400 mg QD)- Based Antiretroviral Therapy [Phase 4]